Spontaneous intracerebral hemorrhage (ICH) has a poor prognosis. Early imaging <72 hours is essential for etiological and prognosis assessment. We aimed to describe early imaging practices and evaluate their etiological relevance, before adopting standardized protocols.
Methods
Acute spontaneous ICH patients from two university centers (2021–2022) were retrospectively included. Data included imaging, lesion, and associated vascular lesions parameters. Etiologies were classified into six categories based on imaging and clinical criteria: arteriolosclerosis, cerebral amyloid angiopathy (CAA), mixed cerebral small vessel disease (cSVD: arteriolosclerosis + CAA), vascular malformation, tumor, or undetermined.
Results
Among 450 patients (71 ± 16 years; 52% male), initial imaging was CT in 58.5%; 53% had MRI <72 hours. 46% of baseline imaging comprised contrast-injection. CT-only patients were older, with larger hematomas and higher in-hospital mortality (all<0.05). ICH (48 ± 47 mL) was predominantly supratentorial (90%), with deep (52%) or lobar (frontal 28%) locations. MRI detected white matter hyperintensities (76%), lacunes (43%), infarcts (14%), acute ischemias (6%), and microbleeds (65%). CT identified an etiology in 50% vs. 80% for MRI (p < .001), mainly mixed cSVD (34%), arteriolosclerosis (23%), CAA (14%), and vascular malformations (7%) when based on MRI. Follow-up imaging <72 h was done in 42%, mostly CT.
Conclusions
Although CT was more frequent, MRI was superior for early etiological assessment of spontaneous ICH, mainly identifying cSVD-related causes. Broader use of early cerebral MRI could contribute to optimizing ICH care by improving identification of mixed cSVD patients and might help prevent secondary bleeding. Prospective and standardized MRI use in the early phase of ICH will clarify its role.
van AschCJLuitseMJRinkelGJ, et al.Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol2010; 9: 167–176.
2.
ZahuranecDBLisabethLDSánchezBN, et al.Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology2014; 82: 2180–2186.
3.
GreenbergSMZiaiWCCordonnierC, et al.2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American heart association/American stroke association. Stroke2022; 53: e282–e361.
4.
GoeldlinMStewartCRadojewskiP, et al.Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts. Expert Rev Neurother2022; 22: 579–594.
5.
JainAMalhotraAPayabvashS. Imaging of spontaneous intracerebral hemorrhage. Neuroimaging Clin N Am2021; 31: 193–203.
6.
MacellariFPaciaroniMAgnelliG, et al.Neuroimaging in intracerebral hemorrhage. Stroke2014; 45: 903–908.
7.
PasiMCharidimouABoulouisG, et al.Mixed-location cerebral hemorrhage/microbleeds: underlying microangiopathy and recurrence risk. Neurology2018; 90: e119–e126.
8.
CordonnierCDemchukAZiaiW, et al.Intracerebral haemorrhage: current approaches to acute management. Lancet2018; 392: 1257–1268.
9.
RaposoNZanon ZotinMCSeiffgeDJ, et al.A causal classification system for intracerebral hemorrhage subtypes. Ann Neurol2023; 93: 16–28.
10.
SteinerTPurruckerJCAguiar de SousaD, et al.European stroke organisation (ESO) and European association of neurosurgical societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage. European Stroke Journal2025: 23969873251340815.
11.
KidwellCSChalelaJASaverJL, et al.Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA2004; 292: 1823–1830.
12.
WilsonMWangJ-YAndreevA, et al.Diagnostic utility of brain MRI in spontaneous intracerebral hemorrhage: a retrospective cohort study and meta-analysis. Eur Stroke J2023; 8: 1089–1096.
13.
CohenJFKorevaarDAAltmanDG, et al.STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open2016; 6: e012799.
TisserandMNaggaraOLegrandL, et al.Patient ‘candidate’ for thrombolysis: MRI is essential. Diagn Interv Imaging2014; 95: 1135–1144.
16.
ScheldemanLWoutersALemmensR. Imaging selection for reperfusion therapy in acute ischemic stroke beyond the conventional time window. J Neurol2022; 269: 1715–1723.
17.
CharidimouABoulouisGFroschMP, et al.The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol2022; 21: 714–725.
18.
BrottTAdamsHPOlingerCP, et al.Measurements of acute cerebral infarction: a clinical examination scale. Stroke1989; 20: 864–870.
19.
TeasdaleGJennettB. Assessment of coma and impaired consciousness. A practical scale. Lancet1974; 2: 81–84.
20.
SaverJLChaisinanunkulNCampbellBCV, et al.Standardized nomenclature for modified rankin scale global disability outcomes: consensus recommendations from stroke therapy academic industry roundtable XI. Stroke2021; 52: 3054–3062.
21.
CharidimouASchmittAWilsonD, et al.The cerebral haemorrhage anatomical RaTing inStrument (CHARTS): development and assessment of reliability. J Neurol Sci2017; 372: 178–183.
22.
PensatoUTanakaKHornM, et al.Co-localization of NCCT hypodensity and CTA spot sign predicts substantial intracerebral hematoma expansion: the Black-&-White sign. Eur Stroke J2025; 10: 181–189.
23.
HornMTelegETanakaK, et al.Timing of spot sign appearance, spot sign volume, and leakage rate among phases of multiphase CTA predict intracerebral hemorrhage growth. AJNR Am J Neuroradiol2024; 45: 693–700.
24.
BaronJ-CBoulouisGBenzakounJ, et al.Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage: diagnostic value of plain CT. J Neurol2022; 269: 2126–2132.
25.
BullockMRChesnutRGhajarJ, et al.Surgical management of traumatic parenchymal lesions. Neurosurgery2006; 58: S25–46, discussion Si-iv.
26.
GregoireSMChaudharyUJBrownMM, et al.The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds. Neurology2009; 73: 1759–1766.
27.
DueringMBiesselsGJBrodtmannA, et al.Neuroimaging standards for research into small vessel disease—advances since 2013. Lancet Neurol2023; 22: 602–618.
28.
van SwietenJCHijdraAKoudstaalPJ, et al.Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry1990; 53: 1080–1083.
29.
FazekasFChawlukJBAlaviA, et al.MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol1987; 149: 351–356.
30.
CharidimouABoulouisGHaleyK, et al.White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology2016; 86: 505–511.
31.
OppenheimCLogakMDormontD, et al.Diagnosis of acute ischaemic stroke with fluid-attenuated inversion recovery and diffusion-weighted sequences. Neuroradiology2000; 42: 602–607.
32.
AllenLMHassoANHandwerkerJ, et al.Sequence-specific MR imaging findings that are useful in dating ischemic stroke. Radiographics2012; 32: 1285–1297.
33.
OppenheimCStanescuRDormontD, et al.False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol2000; 21: 1434–1440.
34.
YamadaNImakitaSSakumaT. Value of diffusion-weighted imaging and apparent diffusion coefficient in recent cerebral infarctions: a correlative study with contrast-enhanced T1-Weighted imaging. AJNR Am J Neuroradiol1999; 20: 193–198.
35.
RodriguesMASamarasekeraNLerpiniereC, et al.The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol2018; 17: 232–240.
36.
Hajj-AliRACalabreseLH. Diagnosis and classification of central nervous system vasculitis. J Autoimmun2014; 48–49: 149–152.
37.
PascarellaRAntonenkoKBoulouisG, et al.European stroke organisation (ESO) guidelines on primary angiitis of the central nervous system (PACNS). Eur Stroke J2023; 8: 842–879.
38.
ZeddeMNapoliMMorattiC, et al.The hemorrhagic side of primary angiitis of the central nervous system (PACNS). Biomedicines2024; 12: 459.
39.
AgarwalSSebastianLJDGaikwadS, et al.The role of susceptibility-weighted imaging & contrast-enhanced MRI in the diagnosis of primary CNS vasculitis: a large case series. Sci Rep2024; 14: 4718.
40.
KaufmannJBueckePMeinelT, et al.Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) - a systematic review. Eur J Neurol2024; 31: e16246.
41.
de BoyssonHParientiJ-JMawetJ, et al.Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: a comparative study. Neurology2018; 91: e1468–e1478.
42.
MainguyRCrombeASeuxM, et al.Assessment of large-scale imaging practices in patients with acute brain hemorrhage in French emergency departments: emergency imaging practices in hemorrhagic stroke. J Neuroradiol2024; 51: 101222.
43.
TranATAbou KaramGZeeviD, et al.Improving the robustness of deep learning models in predicting hematoma expansion from admission head CT. AJNR Am J Neuroradiol2025; 46: 1404–1411.
44.
NadaASayedAAHamoudaM, et al.External validation and performance analysis of a deep learning-based model for the detection of intracranial hemorrhage. NeuroRadiol J2025; 38: 312–321.
45.
HilkensNAvan AschCJJWerringDJ, et al.Predicting the presence of macrovascular causes in non-traumatic intracerebral haemorrhage: the DIAGRAM prediction score. J Neurol Neurosurg Psychiatry2018; 89: 674–679.
46.
WijmanCACVenkatasubramanianCBruinsS, et al.Utility of early MRI in the diagnosis and management of acute spontaneous intracerebral hemorrhage. Cerebrovasc Dis2010; 30: 456–463.
47.
MeretojaAStrbianDPutaalaJ, et al.SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke2012; 43: 2592–2597.
48.
GrossBAJankowitzBTFriedlanderRM. Cerebral intraparenchymal hemorrhage: a review. JAMA2019; 321: 1295–1303.
49.
WangSZhangYWangX, et al.Added value of cerebral small vascular disease burden based on MRI for prediction poor outcome of intracerebral hemorrhage. Clin Neuroradiol. DOI: 10.1007/s00062-025-01517-4, Epub ahead of print 2 May 2025.
50.
AlemanyMStenborgATerentA, et al.Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: correlation with signs of microangiopathy and clinical data. Radiology2006; 238: 240–247.
51.
Martí-FàbregasJPrats-SánchezLMartínez-DomeñoA, et al.The H-ATOMIC criteria for the etiologic classification of patients with intracerebral hemorrhage. PLoS One2016; 11: e0156992.
52.
DownesMHKalagaraRRossittoCP, et al.Validation of the Boston criteria version 2.0 for cerebral amyloid angiopathy in patients presenting with intracerebral hemorrhage. Neurology2025; 104: e213460.
53.
HouYQinWYangS, et al.Diffusion-weighted imaging detection of acute ischemia brain lesions in spontaneous intracerebral hemorrhage associated with white matter hyperintensities, enlarged perivascular spaces and diabetes mellitus. Curr Neurovasc Res2024; 20: 544–552.
54.
GoeldlinMBMuellerMSiepenBM, et al.CADMUS: a novel MRI-based classification of spontaneous intracerebral hemorrhage associated with cerebral small vessel disease. Neurology2024; 102: e207977.
55.
GrangeonLRousselMGillibertA, et al.Applicability of the Edinburgh CT criteria for lobar intracerebral hemorrhage associated with cerebral amyloid angiopathy. Clin Neuroradiol2023; 33: 455–465.
56.
BekelisKDesaiAZhaoW, et al.Computed tomography angiography: improving diagnostic yield and cost effectiveness in the initial evaluation of spontaneous nonsubarachnoid intracerebral hemorrhage. J Neurosurg2012; 117: 761–766.
57.
SaposnikGBarinagarrementeriaFBrownRD, et al.Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American heart association/American stroke association. Stroke2011; 42: 1158–1192.
58.
CohenCLenckSTalbiA, et al.Intracranial dural arteriovenous fistulas: association with cerebral venous thrombosis, baseline aggressiveness, and clinical outcomes. A retrospective multicenter study on 263 consecutive patients and literature review. Neurosurg Focus2024; 56: E9.
NaviBBReichmanJSBerlinD, et al.Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology2010; 74: 494–501.
61.
VelanderAJDeAngelisLMNaviBB. Intracranial hemorrhage in patients with cancer. Curr Atheroscler Rep2012; 14: 373–381.
62.
SteinerTRosandJDiringerM. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke2006; 37: 256–262.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
